 | • レポートコード：GIR-107A12368 • 出版社/出版日：GlobalInfoResearch / 2021年7月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、85ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料では、免疫性炎症性疾患治療のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。免疫性炎症性疾患治療の種類別市場規模（ターゲット生物学的療法、新規療法）、用途別市場規模（病院、薬局店、オンライン薬局）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・免疫性炎症性疾患治療の市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：GlaxoSmithKline、Eli Lilly、AstraZeneca、Bristol-Myers、Sanofi、Roche、Enlivex Therapeutics、Immune Pharmaceuticals、Tanabe Pharma ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：ターゲット生物学的療法、新規療法 ・用途別分析2016年-2026年：病院、薬局店、オンライン薬局 ・免疫性炎症性疾患治療の北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・免疫性炎症性疾患治療のヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・免疫性炎症性疾患治療のアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・免疫性炎症性疾患治療の南米市場規模2016年-2026年：ブラジル、アルゼンチン ・免疫性炎症性疾患治療の中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Immune-Mediated Inflammatory Diseases Treatment market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Immune-Mediated Inflammatory Diseases Treatment size is estimated to be USD xx million in 2026 from USD xx million in 2020, with a change XX% between 2020 and 2021. The global Immune-Mediated Inflammatory Diseases Treatment market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
Immune-Mediated Inflammatory Diseases Treatment market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Targeted biologic therapies
Novel therapies
Market segment by Application, can be divided into
Hospitals
Pharmacy Store
Online Pharmacy Stroe
Market segment by players, this report covers
GlaxoSmithKline
Eli Lilly
AstraZeneca
Bristol-Myers
Sanofi
Roche
Enlivex Therapeutics
Immune Pharmaceuticals
Tanabe Pharma
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 12 chapters:
Chapter 1, to describe Immune-Mediated Inflammatory Diseases Treatment product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top players of Immune-Mediated Inflammatory Diseases Treatment, with revenue, gross margin and global market share of Immune-Mediated Inflammatory Diseases Treatment from 2019 to 2021.
Chapter 3, the Immune-Mediated Inflammatory Diseases Treatment competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by type and application, with revenue and growth rate by type, application, from 2016 to 2026.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2016 to 2021.and Immune-Mediated Inflammatory Diseases Treatment market forecast, by regions, type and application, with revenue, from 2021 to 2026.
Chapter 11 and 12, to describe Immune-Mediated Inflammatory Diseases Treatment research findings and conclusion, appendix and data source.
1 Market Overview
1.1 Product Overview and Scope of Immune-Mediated Inflammatory Diseases Treatment
1.2 Classification of Immune-Mediated Inflammatory Diseases Treatment by Type
1.2.1 Overview: Global Immune-Mediated Inflammatory Diseases Treatment Market Size by Type: 2020 Versus 2021 Versus 2026
1.2.2 Global Immune-Mediated Inflammatory Diseases Treatment Revenue Market Share by Type in 2020
1.2.3 Targeted biologic therapies
1.2.4 Novel therapies
1.3 Global Immune-Mediated Inflammatory Diseases Treatment Market by Application
1.3.1 Overview: Global Immune-Mediated Inflammatory Diseases Treatment Market Size by Application: 2020 Versus 2021 Versus 2026
1.3.2 Hospitals
1.3.3 Pharmacy Store
1.3.4 Online Pharmacy Stroe
1.4 Global Immune-Mediated Inflammatory Diseases Treatment Market Size & Forecast
1.5 Global Immune-Mediated Inflammatory Diseases Treatment Market Size and Forecast by Region
1.5.1 Global Immune-Mediated Inflammatory Diseases Treatment Market Size by Region: 2016 VS 2021 VS 2026
1.5.2 Global Immune-Mediated Inflammatory Diseases Treatment Market Size by Region, (2016-2021)
1.5.3 North America Immune-Mediated Inflammatory Diseases Treatment Market Size and Prospect (2016-2026)
1.5.4 Europe Immune-Mediated Inflammatory Diseases Treatment Market Size and Prospect (2016-2026)
1.5.5 Asia-Pacific Immune-Mediated Inflammatory Diseases Treatment Market Size and Prospect (2016-2026)
1.5.6 South America Immune-Mediated Inflammatory Diseases Treatment Market Size and Prospect (2016-2026)
1.5.7 Middle East and Africa Immune-Mediated Inflammatory Diseases Treatment Market Size and Prospect (2016-2026)
1.6 Market Drivers, Restraints and Trends
1.6.1 Immune-Mediated Inflammatory Diseases Treatment Market Drivers
1.6.2 Immune-Mediated Inflammatory Diseases Treatment Market Restraints
1.6.3 Immune-Mediated Inflammatory Diseases Treatment Trends Analysis
2 Company Profiles
2.1 GlaxoSmithKline
2.1.1 GlaxoSmithKline Details
2.1.2 GlaxoSmithKline Major Business
2.1.3 GlaxoSmithKline Immune-Mediated Inflammatory Diseases Treatment Product and Solutions
2.1.4 GlaxoSmithKline Immune-Mediated Inflammatory Diseases Treatment Revenue, Gross Margin and Market Share (2019-2021)
2.1.5 GlaxoSmithKline Recent Developments and Future Plans
2.2 Eli Lilly
2.2.1 Eli Lilly Details
2.2.2 Eli Lilly Major Business
2.2.3 Eli Lilly Immune-Mediated Inflammatory Diseases Treatment Product and Solutions
2.2.4 Eli Lilly Immune-Mediated Inflammatory Diseases Treatment Revenue, Gross Margin and Market Share (2019-2021)
2.2.5 Eli Lilly Recent Developments and Future Plans
2.3 AstraZeneca
2.3.1 AstraZeneca Details
2.3.2 AstraZeneca Major Business
2.3.3 AstraZeneca Immune-Mediated Inflammatory Diseases Treatment Product and Solutions
2.3.4 AstraZeneca Immune-Mediated Inflammatory Diseases Treatment Revenue, Gross Margin and Market Share (2019-2021)
2.3.5 AstraZeneca Recent Developments and Future Plans
2.4 Bristol-Myers
2.4.1 Bristol-Myers Details
2.4.2 Bristol-Myers Major Business
2.4.3 Bristol-Myers Immune-Mediated Inflammatory Diseases Treatment Product and Solutions
2.4.4 Bristol-Myers Immune-Mediated Inflammatory Diseases Treatment Revenue, Gross Margin and Market Share (2019-2021)
2.4.5 Bristol-Myers Recent Developments and Future Plans
2.5 Sanofi
2.5.1 Sanofi Details
2.5.2 Sanofi Major Business
2.5.3 Sanofi Immune-Mediated Inflammatory Diseases Treatment Product and Solutions
2.5.4 Sanofi Immune-Mediated Inflammatory Diseases Treatment Revenue, Gross Margin and Market Share (2019-2021)
2.5.5 Sanofi Recent Developments and Future Plans
2.6 Roche
2.6.1 Roche Details
2.6.2 Roche Major Business
2.6.3 Roche Immune-Mediated Inflammatory Diseases Treatment Product and Solutions
2.6.4 Roche Immune-Mediated Inflammatory Diseases Treatment Revenue, Gross Margin and Market Share (2019-2021)
2.6.5 Roche Recent Developments and Future Plans
2.7 Enlivex Therapeutics
2.7.1 Enlivex Therapeutics Details
2.7.2 Enlivex Therapeutics Major Business
2.7.3 Enlivex Therapeutics Immune-Mediated Inflammatory Diseases Treatment Product and Solutions
2.7.4 Enlivex Therapeutics Immune-Mediated Inflammatory Diseases Treatment Revenue, Gross Margin and Market Share (2019-2021)
2.7.5 Enlivex Therapeutics Recent Developments and Future Plans
2.8 Immune Pharmaceuticals
2.8.1 Immune Pharmaceuticals Details
2.8.2 Immune Pharmaceuticals Major Business
2.8.3 Immune Pharmaceuticals Immune-Mediated Inflammatory Diseases Treatment Product and Solutions
2.8.4 Immune Pharmaceuticals Immune-Mediated Inflammatory Diseases Treatment Revenue, Gross Margin and Market Share (2019-2021)
2.8.5 Immune Pharmaceuticals Recent Developments and Future Plans
2.9 Tanabe Pharma
2.9.1 Tanabe Pharma Details
2.9.2 Tanabe Pharma Major Business
2.9.3 Tanabe Pharma Immune-Mediated Inflammatory Diseases Treatment Product and Solutions
2.9.4 Tanabe Pharma Immune-Mediated Inflammatory Diseases Treatment Revenue, Gross Margin and Market Share (2019-2021)
2.9.5 Tanabe Pharma Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Immune-Mediated Inflammatory Diseases Treatment Revenue and Share by Players (2019-2021)
3.2 Market Concentration Rate
3.2.1 Top 3 Immune-Mediated Inflammatory Diseases Treatment Players Market Share
3.2.2 Top 10 Immune-Mediated Inflammatory Diseases Treatment Players Market Share
3.2.3 Market Competition Trend
3.3 Immune-Mediated Inflammatory Diseases Treatment Players Head Office, Products and Services Provided
3.4 Mergers & Acquisitions
3.5 New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global Immune-Mediated Inflammatory Diseases Treatment Revenue and Market Share by Type (2016-2021)
4.2 Global Immune-Mediated Inflammatory Diseases Treatment Market Forecast by Type (2021-2026)
5 Market Size Segment by Application
5.1 Global Immune-Mediated Inflammatory Diseases Treatment Revenue Market Share by Application (2016-2021)
5.2 Immune-Mediated Inflammatory Diseases Treatment Market Forecast by Application (2021-2026)
6 North America by Country, by Type, and by Application
6.1 North America Immune-Mediated Inflammatory Diseases Treatment Revenue by Type (2016-2026)
6.2 North America Immune-Mediated Inflammatory Diseases Treatment Revenue by Application (2016-2026)
6.3 North America Immune-Mediated Inflammatory Diseases Treatment Market Size by Country
6.3.1 North America Immune-Mediated Inflammatory Diseases Treatment Revenue by Country (2016-2026)
6.3.2 United States Immune-Mediated Inflammatory Diseases Treatment Market Size and Forecast (2016-2026)
6.3.3 Canada Immune-Mediated Inflammatory Diseases Treatment Market Size and Forecast (2016-2026)
6.3.4 Mexico Immune-Mediated Inflammatory Diseases Treatment Market Size and Forecast (2016-2026)
7 Europe by Country, by Type, and by Application
7.1 Europe Immune-Mediated Inflammatory Diseases Treatment Revenue by Type (2016-2026)
7.2 Europe Immune-Mediated Inflammatory Diseases Treatment Revenue by Application (2016-2026)
7.3 Europe Immune-Mediated Inflammatory Diseases Treatment Market Size by Country
7.3.1 Europe Immune-Mediated Inflammatory Diseases Treatment Revenue by Country (2016-2026)
7.3.2 Germany Immune-Mediated Inflammatory Diseases Treatment Market Size and Forecast (2016-2026)
7.3.3 France Immune-Mediated Inflammatory Diseases Treatment Market Size and Forecast (2016-2026)
7.3.4 United Kingdom Immune-Mediated Inflammatory Diseases Treatment Market Size and Forecast (2016-2026)
7.3.5 Russia Immune-Mediated Inflammatory Diseases Treatment Market Size and Forecast (2016-2026)
7.3.6 Italy Immune-Mediated Inflammatory Diseases Treatment Market Size and Forecast (2016-2026)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Immune-Mediated Inflammatory Diseases Treatment Revenue by Type (2016-2026)
8.2 Asia-Pacific Immune-Mediated Inflammatory Diseases Treatment Revenue by Application (2016-2026)
8.3 Asia-Pacific Immune-Mediated Inflammatory Diseases Treatment Market Size by Region
8.3.1 Asia-Pacific Immune-Mediated Inflammatory Diseases Treatment Revenue by Region (2016-2026)
8.3.2 China Immune-Mediated Inflammatory Diseases Treatment Market Size and Forecast (2016-2026)
8.3.3 Japan Immune-Mediated Inflammatory Diseases Treatment Market Size and Forecast (2016-2026)
8.3.4 South Korea Immune-Mediated Inflammatory Diseases Treatment Market Size and Forecast (2016-2026)
8.3.5 India Immune-Mediated Inflammatory Diseases Treatment Market Size and Forecast (2016-2026)
8.3.6 Southeast Asia Immune-Mediated Inflammatory Diseases Treatment Market Size and Forecast (2016-2026)
8.3.7 Australia Immune-Mediated Inflammatory Diseases Treatment Market Size and Forecast (2016-2026)
9 South America by Country, by Type, and by Application
9.1 South America Immune-Mediated Inflammatory Diseases Treatment Revenue by Type (2016-2026)
9.2 South America Immune-Mediated Inflammatory Diseases Treatment Revenue by Application (2016-2026)
9.3 South America Immune-Mediated Inflammatory Diseases Treatment Market Size by Country
9.3.1 South America Immune-Mediated Inflammatory Diseases Treatment Revenue by Country (2016-2026)
9.3.2 Brazil Immune-Mediated Inflammatory Diseases Treatment Market Size and Forecast (2016-2026)
9.3.3 Argentina Immune-Mediated Inflammatory Diseases Treatment Market Size and Forecast (2016-2026)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Immune-Mediated Inflammatory Diseases Treatment Revenue by Type (2016-2026)
10.2 Middle East & Africa Immune-Mediated Inflammatory Diseases Treatment Revenue by Application (2016-2026)
10.3 Middle East & Africa Immune-Mediated Inflammatory Diseases Treatment Market Size by Country
10.3.1 Middle East & Africa Immune-Mediated Inflammatory Diseases Treatment Revenue by Country (2016-2026)
10.3.2 Turkey Immune-Mediated Inflammatory Diseases Treatment Market Size and Forecast (2016-2026)
10.3.3 Saudi Arabia Immune-Mediated Inflammatory Diseases Treatment Market Size and Forecast (2016-2026)
10.3.4 UAE Immune-Mediated Inflammatory Diseases Treatment Market Size and Forecast (2016-2026)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
Table 1. Global Immune-Mediated Inflammatory Diseases Treatment Revenue by Type, (USD Million), 2020 VS 2021 VS 2026
Table 2. Global Immune-Mediated Inflammatory Diseases Treatment Revenue by Application, (USD Million), 2020 VS 2021 VS 2026
Table 3. Global Market Immune-Mediated Inflammatory Diseases Treatment Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)
Table 4. Global Immune-Mediated Inflammatory Diseases Treatment Revenue (USD Million) by Region (2016-2021)
Table 5. Global Immune-Mediated Inflammatory Diseases Treatment Revenue Market Share by Region (2021-2026)
Table 6. GlaxoSmithKline Corporate Information, Head Office, and Major Competitors
Table 7. GlaxoSmithKline Major Business
Table 8. GlaxoSmithKline Immune-Mediated Inflammatory Diseases Treatment Product and Solutions
Table 9. GlaxoSmithKline Immune-Mediated Inflammatory Diseases Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 10. Eli Lilly Corporate Information, Head Office, and Major Competitors
Table 11. Eli Lilly Major Business
Table 12. Eli Lilly Immune-Mediated Inflammatory Diseases Treatment Product and Solutions
Table 13. Eli Lilly Immune-Mediated Inflammatory Diseases Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 14. AstraZeneca Corporate Information, Head Office, and Major Competitors
Table 15. AstraZeneca Major Business
Table 16. AstraZeneca Immune-Mediated Inflammatory Diseases Treatment Product and Solutions
Table 17. AstraZeneca Immune-Mediated Inflammatory Diseases Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 18. Bristol-Myers Corporate Information, Head Office, and Major Competitors
Table 19. Bristol-Myers Major Business
Table 20. Bristol-Myers Immune-Mediated Inflammatory Diseases Treatment Product and Solutions
Table 21. Bristol-Myers Immune-Mediated Inflammatory Diseases Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 22. Sanofi Corporate Information, Head Office, and Major Competitors
Table 23. Sanofi Major Business
Table 24. Sanofi Immune-Mediated Inflammatory Diseases Treatment Product and Solutions
Table 25. Sanofi Immune-Mediated Inflammatory Diseases Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 26. Roche Corporate Information, Head Office, and Major Competitors
Table 27. Roche Major Business
Table 28. Roche Immune-Mediated Inflammatory Diseases Treatment Product and Solutions
Table 29. Roche Immune-Mediated Inflammatory Diseases Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 30. Enlivex Therapeutics Corporate Information, Head Office, and Major Competitors
Table 31. Enlivex Therapeutics Major Business
Table 32. Enlivex Therapeutics Immune-Mediated Inflammatory Diseases Treatment Product and Solutions
Table 33. Enlivex Therapeutics Immune-Mediated Inflammatory Diseases Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 34. Immune Pharmaceuticals Corporate Information, Head Office, and Major Competitors
Table 35. Immune Pharmaceuticals Major Business
Table 36. Immune Pharmaceuticals Immune-Mediated Inflammatory Diseases Treatment Product and Solutions
Table 37. Immune Pharmaceuticals Immune-Mediated Inflammatory Diseases Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 38. Tanabe Pharma Corporate Information, Head Office, and Major Competitors
Table 39. Tanabe Pharma Major Business
Table 40. Tanabe Pharma Immune-Mediated Inflammatory Diseases Treatment Product and Solutions
Table 41. Tanabe Pharma Immune-Mediated Inflammatory Diseases Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 42. Global Immune-Mediated Inflammatory Diseases Treatment Revenue (USD Million) by Players (2019-2021)
Table 43. Global Immune-Mediated Inflammatory Diseases Treatment Revenue Share by Players (2019-2021)
Table 44. Breakdown of Immune-Mediated Inflammatory Diseases Treatment by Company Type (Tier 1, Tier 2 and Tier 3)
Table 45. Immune-Mediated Inflammatory Diseases Treatment Players Head Office, Products and Services Provided
Table 46. Immune-Mediated Inflammatory Diseases Treatment Mergers & Acquisitions in the Past Five Years
Table 47. Immune-Mediated Inflammatory Diseases Treatment New Entrants and Expansion Plans
Table 48. Global Immune-Mediated Inflammatory Diseases Treatment Revenue (USD Million) by Type (2016-2021)
Table 49. Global Immune-Mediated Inflammatory Diseases Treatment Revenue Share by Type (2016-2021)
Table 50. Global Immune-Mediated Inflammatory Diseases Treatment Revenue Forecast by Type (2021-2026)
Table 51. Global Immune-Mediated Inflammatory Diseases Treatment Revenue by Application (2016-2021)
Table 52. Global Immune-Mediated Inflammatory Diseases Treatment Revenue Forecast by Application (2021-2026)
Table 53. North America Immune-Mediated Inflammatory Diseases Treatment Revenue by Type (2016-2021) & (USD Million)
Table 54. North America Immune-Mediated Inflammatory Diseases Treatment Revenue by Type (2021-2026) & (USD Million)
Table 55. North America Immune-Mediated Inflammatory Diseases Treatment Revenue by Application (2016-2021) & (USD Million)
Table 56. North America Immune-Mediated Inflammatory Diseases Treatment Revenue by Application (2021-2026) & (USD Million)
Table 57. North America Immune-Mediated Inflammatory Diseases Treatment Revenue by Country (2016-2021) & (USD Million)
Table 58. North America Immune-Mediated Inflammatory Diseases Treatment Revenue by Country (2021-2026) & (USD Million)
Table 59. Europe Immune-Mediated Inflammatory Diseases Treatment Revenue by Type (2016-2021) & (USD Million)
Table 60. Europe Immune-Mediated Inflammatory Diseases Treatment Revenue by Type (2021-2026) & (USD Million)
Table 61. Europe Immune-Mediated Inflammatory Diseases Treatment Revenue by Application (2016-2021) & (USD Million)
Table 62. Europe Immune-Mediated Inflammatory Diseases Treatment Revenue by Application (2021-2026) & (USD Million)
Table 63. Europe Immune-Mediated Inflammatory Diseases Treatment Revenue by Country (2016-2021) & (USD Million)
Table 64. Europe Immune-Mediated Inflammatory Diseases Treatment Revenue by Country (2021-2026) & (USD Million)
Table 65. Asia-Pacific Immune-Mediated Inflammatory Diseases Treatment Revenue by Type (2016-2021) & (USD Million)
Table 66. Asia-Pacific Immune-Mediated Inflammatory Diseases Treatment Revenue by Type (2021-2026) & (USD Million)
Table 67. Asia-Pacific Immune-Mediated Inflammatory Diseases Treatment Revenue by Application (2016-2021) & (USD Million)
Table 68. Asia-Pacific Immune-Mediated Inflammatory Diseases Treatment Revenue by Application (2021-2026) & (USD Million)
Table 69. Asia-Pacific Immune-Mediated Inflammatory Diseases Treatment Revenue by Region (2016-2021) & (USD Million)
Table 70. Asia-Pacific Immune-Mediated Inflammatory Diseases Treatment Revenue by Region (2021-2026) & (USD Million)
Table 71. South America Immune-Mediated Inflammatory Diseases Treatment Revenue by Type (2016-2021) & (USD Million)
Table 72. South America Immune-Mediated Inflammatory Diseases Treatment Revenue by Type (2021-2026) & (USD Million)
Table 73. South America Immune-Mediated Inflammatory Diseases Treatment Revenue by Application (2016-2021) & (USD Million)
Table 74. South America Immune-Mediated Inflammatory Diseases Treatment Revenue by Application (2021-2026) & (USD Million)
Table 75. South America Immune-Mediated Inflammatory Diseases Treatment Revenue by Country (2016-2021) & (USD Million)
Table 76. South America Immune-Mediated Inflammatory Diseases Treatment Revenue by Country (2021-2026) & (USD Million)
Table 77. Middle East & Africa Immune-Mediated Inflammatory Diseases Treatment Revenue by Type (2016-2021) & (USD Million)
Table 78. Middle East & Africa Immune-Mediated Inflammatory Diseases Treatment Revenue by Type (2021-2026) & (USD Million)
Table 79. Middle East & Africa Immune-Mediated Inflammatory Diseases Treatment Revenue by Application (2016-2021) & (USD Million)
Table 80. Middle East & Africa Immune-Mediated Inflammatory Diseases Treatment Revenue by Application (2021-2026) & (USD Million)
Table 81. Middle East & Africa Immune-Mediated Inflammatory Diseases Treatment Revenue by Country (2016-2021) & (USD Million)
Table 82. Middle East & Africa Immune-Mediated Inflammatory Diseases Treatment Revenue by Country (2021-2026) & (USD Million)
List of Figures
Figure 1. Immune-Mediated Inflammatory Diseases Treatment Picture
Figure 2. Global Immune-Mediated Inflammatory Diseases Treatment Revenue Market Share by Type in 2020
Figure 3. Targeted biologic therapies
Figure 4. Novel therapies
Figure 5. Immune-Mediated Inflammatory Diseases Treatment Revenue Market Share by Application in 2020
Figure 6. Hospitals Picture
Figure 7. Pharmacy Store Picture
Figure 8. Online Pharmacy Stroe Picture
Figure 9. Global Immune-Mediated Inflammatory Diseases Treatment Revenue, (USD Million): 2020 VS 2021 VS 2026
Figure 10. Global Immune-Mediated Inflammatory Diseases Treatment Revenue and Forecast (2016-2026) & (USD Million)
Figure 11. Global Immune-Mediated Inflammatory Diseases Treatment Revenue Market Share by Region (2016-2026)
Figure 12. Global Immune-Mediated Inflammatory Diseases Treatment Revenue Market Share by Region in 2020
Figure 13. North America Immune-Mediated Inflammatory Diseases Treatment Revenue (USD Million) and Growth Rate (2016-2026)
Figure 14. Europe Immune-Mediated Inflammatory Diseases Treatment Revenue (USD Million) and Growth Rate (2016-2026)
Figure 15. Asia-Pacific Immune-Mediated Inflammatory Diseases Treatment Revenue (USD Million) and Growth Rate (2016-2026)
Figure 16. South America Immune-Mediated Inflammatory Diseases Treatment Revenue (USD Million) and Growth Rate (2016-2026)
Figure 17. Middle East and Africa Immune-Mediated Inflammatory Diseases Treatment Revenue (USD Million) and Growth Rate (2016-2026)
Figure 18. Immune-Mediated Inflammatory Diseases Treatment Market Drivers
Figure 19. Immune-Mediated Inflammatory Diseases Treatment Market Restraints
Figure 20. Immune-Mediated Inflammatory Diseases Treatment Market Trends
Figure 21. GlaxoSmithKline Recent Developments and Future Plans
Figure 22. Eli Lilly Recent Developments and Future Plans
Figure 23. AstraZeneca Recent Developments and Future Plans
Figure 24. Bristol-Myers Recent Developments and Future Plans
Figure 25. Sanofi Recent Developments and Future Plans
Figure 26. Roche Recent Developments and Future Plans
Figure 27. Enlivex Therapeutics Recent Developments and Future Plans
Figure 28. Immune Pharmaceuticals Recent Developments and Future Plans
Figure 29. Tanabe Pharma Recent Developments and Future Plans
Figure 30. Global Immune-Mediated Inflammatory Diseases Treatment Revenue Share by Players in 2020
Figure 31. Immune-Mediated Inflammatory Diseases Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
Figure 32. Global Top 3 Players Immune-Mediated Inflammatory Diseases Treatment Revenue Market Share in 2020
Figure 33. Global Top 10 Players Immune-Mediated Inflammatory Diseases Treatment Revenue Market Share in 2020
Figure 34. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)
Figure 35. Global Immune-Mediated Inflammatory Diseases Treatment Revenue Share by Type in 2020
Figure 36. Global Immune-Mediated Inflammatory Diseases Treatment Market Share Forecast by Type (2021-2026)
Figure 37. Global Immune-Mediated Inflammatory Diseases Treatment Revenue Share by Application in 2020
Figure 38. Global Immune-Mediated Inflammatory Diseases Treatment Market Share Forecast by Application (2021-2026)
Figure 39. North America Immune-Mediated Inflammatory Diseases Treatment Sales Market Share by Type (2016-2026)
Figure 40. North America Immune-Mediated Inflammatory Diseases Treatment Sales Market Share by Application (2016-2026)
Figure 41. North America Immune-Mediated Inflammatory Diseases Treatment Revenue Market Share by Country (2016-2026)
Figure 42. United States Immune-Mediated Inflammatory Diseases Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 43. Canada Immune-Mediated Inflammatory Diseases Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 44. Mexico Immune-Mediated Inflammatory Diseases Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 45. Europe Immune-Mediated Inflammatory Diseases Treatment Sales Market Share by Type (2016-2026)
Figure 46. Europe Immune-Mediated Inflammatory Diseases Treatment Sales Market Share by Application (2016-2026)
Figure 47. Europe Immune-Mediated Inflammatory Diseases Treatment Revenue Market Share by Country (2016-2026)
Figure 48. Germany Immune-Mediated Inflammatory Diseases Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 49. France Immune-Mediated Inflammatory Diseases Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 50. United Kingdom Immune-Mediated Inflammatory Diseases Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 51. Russia Immune-Mediated Inflammatory Diseases Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 52. Italy Immune-Mediated Inflammatory Diseases Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 53. Asia-Pacific Immune-Mediated Inflammatory Diseases Treatment Sales Market Share by Type (2016-2026)
Figure 54. Asia-Pacific Immune-Mediated Inflammatory Diseases Treatment Sales Market Share by Application (2016-2026)
Figure 55. Asia-Pacific Immune-Mediated Inflammatory Diseases Treatment Revenue Market Share by Region (2016-2026)
Figure 56. China Immune-Mediated Inflammatory Diseases Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 57. Japan Immune-Mediated Inflammatory Diseases Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 58. South Korea Immune-Mediated Inflammatory Diseases Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 59. India Immune-Mediated Inflammatory Diseases Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 60. Southeast Asia Immune-Mediated Inflammatory Diseases Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 61. Australia Immune-Mediated Inflammatory Diseases Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 62. South America Immune-Mediated Inflammatory Diseases Treatment Sales Market Share by Type (2016-2026)
Figure 63. South America Immune-Mediated Inflammatory Diseases Treatment Sales Market Share by Application (2016-2026)
Figure 64. South America Immune-Mediated Inflammatory Diseases Treatment Revenue Market Share by Country (2016-2026)
Figure 65. Brazil Immune-Mediated Inflammatory Diseases Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 66. Argentina Immune-Mediated Inflammatory Diseases Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 67. Middle East and Africa Immune-Mediated Inflammatory Diseases Treatment Sales Market Share by Type (2016-2026)
Figure 68. Middle East and Africa Immune-Mediated Inflammatory Diseases Treatment Sales Market Share by Application (2016-2026)
Figure 69. Middle East and Africa Immune-Mediated Inflammatory Diseases Treatment Revenue Market Share by Country (2016-2026)
Figure 70. Turkey Immune-Mediated Inflammatory Diseases Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 71. Saudi Arabia Immune-Mediated Inflammatory Diseases Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 72. UAE Immune-Mediated Inflammatory Diseases Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 73. Methodology
Figure 74. Research Process and Data Source
世界の炎症性皮膚病治療市場 2021：企業別、地域別、種類・用途別 The Inflammatory Skin Diseases Treatment market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, …- 世界の炎症性皮膚病治療薬市場 2021：企業別、地域別、種類・用途別 The Inflammatory Skin Diseases Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trad…
- 世界の静脈内免疫グロブリン療法市場 2021：企業別、地域別、種類・用途別 The Intravenous Immune Globulin Therapies market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization,…
- 世界の炎症性腸疾患治療市場 2021：企業別、地域別、種類・用途別 The Inflammatory Bowel Disease Therapy market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, tr…
- 世界の免疫阻害剤市場 2021：企業別、地域別、種類・用途別 The Immune Anti-Inhibitor market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulatio…